CD8A and laryngotracheoesophageal cleft: Despite these limitations, this nomogram based on the baseline of lung metastasis, NLR, LMR, and CD3+CD8+ T cell count represents a prognostic effect on LC patients with PD-1/PD-L1 inhibitors.